INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $17.56 | 3,655 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 301 | $17.57 | 3,354 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 184 | $17.58 | 3,170 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 43 | $17.60 | 3,127 |
| Jan 09, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 7 | $16.87 | 66,819 |
| Jan 09, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 9 | $16.88 | 66,810 |
| Jan 09, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 30 | $16.91 | 66,780 |
| Jan 09, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 34 | $16.92 | 66,746 |
| Jan 09, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 30 | $16.98 | 66,716 |
| Jan 09, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 74 | $16.99 | 66,642 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.